Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
about
A review of arsenic trioxide and acute promyelocytic leukemiaCardiac monitoring of patients receiving arsenic trioxide therapy.Receptor induction and targeted drug delivery: a new antileukaemia strategy.Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.Arsenic trioxide in the treatment of haematological malignancies.Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.Role of arsenic trioxide in acute promyelocytic leukemia.Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells.Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide.Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impact.
P2860
Q28087768-BBDB309F-80EF-43FE-8FC1-29B007C2329BQ34545365-E931014E-6331-4E3B-8DA9-DFA5BBF60718Q35164785-E6AF9093-F4C8-4E59-8C76-2FB67A65D563Q35561038-F93DB17B-186B-4C20-8B5E-44980BF2F7C3Q35925650-7F0770A5-E8FE-47B9-B89F-F2C9C6563DEDQ37929546-BF2F6663-D8F6-4CB4-939B-AFF3B8965FB8Q39484903-2C1D634B-1E2C-4D0F-86D4-ACF40A71D11DQ42704056-BD3B1F52-E3E7-485A-B634-1E959405AA25Q43936451-0ACEE679-2D61-4EE1-8017-DC758E1EABE5Q45114054-75F9E719-B944-4B7F-973D-11834BDA3FE7Q47608256-719FBA32-0556-457D-9B8C-3A2562FF28C4
P2860
Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Arsenic trioxide- and idarubic ...... lar features of a pilot study.
@en
Arsenic trioxide- and idarubic ...... lar features of a pilot study.
@nl
type
label
Arsenic trioxide- and idarubic ...... lar features of a pilot study.
@en
Arsenic trioxide- and idarubic ...... lar features of a pilot study.
@nl
prefLabel
Arsenic trioxide- and idarubic ...... lar features of a pilot study.
@en
Arsenic trioxide- and idarubic ...... lar features of a pilot study.
@nl
P2093
P2860
P356
P1476
Arsenic trioxide- and idarubic ...... lar features of a pilot study.
@en
P2093
P2860
P304
P356
10.1002/AJH.1057
P577
2001-04-01T00:00:00Z